# Efficacy and Safety of Two Treatment Regimens of Topical MOB015 in Adults With Distal Subungual Onychomycosis

> **NCT01246518** · PHASE2 · COMPLETED · sponsor: **Moberg Pharma AB** · enrollment: 250 (estimated)

## Conditions studied

- Onychomycosis

## Interventions

- **DRUG:** MOB015

## Key facts

- **NCT ID:** NCT01246518
- **Lead sponsor:** Moberg Pharma AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2012-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01246518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01246518, "Efficacy and Safety of Two Treatment Regimens of Topical MOB015 in Adults With Distal Subungual Onychomycosis". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT01246518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*